|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.10 GBX | +1.19% |
|
-0.78% | +7.35% |
| 03-05 | EARNINGS AND TRADING: MicroSalt wins order; Seraphim NAV up | AN |
| 03-05 | Hansard Global plc Reports Earnings Results for the Half Year Ended December 31, 2025 | CI |
| Capitalization | 69.77M 92.36M 80.73M 72.94M 127M 8.54B 132M 871M 345M 4.08B 347M 339M 14.74B | P/E ratio 2026 * |
-
| P/E ratio 2027 * | - |
|---|---|---|---|---|---|
| Enterprise value | 69.77M 92.36M 80.73M 72.94M 127M 8.54B 132M 871M 345M 4.08B 347M 339M 14.74B | EV / Sales 2026 * |
0.75x | EV / Sales 2027 * | 0.68x |
| Free-Float |
38.46% | Yield 2026 * |
8.81% | Yield 2027 * | 8.81% |
| 1 day | -0.30% | ||
| 1 week | -0.78% | ||
| Current month | -1.26% | ||
| 1 month | -0.78% | ||
| 3 months | +6.24% | ||
| 6 months | +0.49% | ||
| Current year | +7.35% |
| 1 week | 48.76 |  | 53 |
| 1 month | 46.8 | | 54.5 |
| Current year | 46 | | 55 |
| 1 year | 41 | | 55 |
| 3 years | 37.2 | | 56 |
| 5 years | 32.4 | | 66.82 |
| 10 years | 23.4 | | 142.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Morfett
CEO | Chief Executive Officer | - | 01/08/2024 |
Ollie Byrne
DFI | Director of Finance/CFO | - | 30/09/2024 |
John Whitehouse
COO | Chief Operating Officer | - | 30/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Polonsky
BRD | Director/Board Member | - | 25/09/2018 |
Philip Kay
CHM | Chairman | 70 | 30/04/2022 |
Ollie Byrne
BRD | Director/Board Member | - | 30/09/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | -0.78% | +7.13% | +7.35% | 92.07M | |
| -1.20% | -1.89% | +80.23% | +116.33% | 155B | |
| -3.02% | -3.88% | +28.21% | +0.31% | 113B | |
| -3.01% | -7.23% | +3.79% | +29.76% | 54.58B | |
| -1.45% | -2.65% | +0.90% | +70.77% | 38.33B | |
| -1.14% | -5.39% | +14.61% | +44.58% | 31.8B | |
| -1.80% | -2.09% | +35.16% | +73.77% | 21.07B | |
| -1.14% | -0.60% | +35.52% | +77.42% | 20.18B | |
| -3.09% | -8.56% | -0.99% | +27.64% | 15.09B | |
| -0.56% | -5.40% | +25.36% | +93.03% | 11.25B | |
| Average | -1.67% | -2.14% | +22.99% | +54.10% | 46.05B | |
| Weighted average by Cap. | -1.95% | -1.47% | +39.21% | +61.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 93.06M 123M 108M 97.28M 169M 11.39B 176M 1.16B 461M 5.44B 462M 452M 19.66B | 102M 136M 118M 107M 186M 12.53B 194M 1.28B 507M 5.99B 508M 498M 21.63B |
| Net income | - | - |
| Net Debt | - | - |
Employees
181
Sector
Life & Health Insurance
Calendar
09-24 -
Earnings release - Annual 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/03/26 | 51.10 p | +1.19% | 116,350 |
| 12/03/26 | 50.50 p | -1.94% | 41,787 |
| 11/03/26 | 51.50 p | +1.98% | 57,946 |
| 10/03/26 | 50.50 p | +2.23% | 144,609 |
| 09/03/26 | 49.40 p | -4.08% | 50,589 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5050GBP
Average target price
0.6500GBP
Spread / Average Target
+28.71%
Annual profits - Rate of surprise
- Stock Market
- Equities
- HSD Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition